New DNA vaccine shows promise in COVID-19 trial
NCT ID NCT04673149
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 33 times
Summary
This study tested a new DNA vaccine called GLS-5310 to see if it is safe and can protect against COVID-19. Healthy adults aged 19 to 85 received the vaccine or a placebo. Researchers measured side effects and immune responses, including antibodies and T cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Korea University Guro Hospital
Seoul, 08308, South Korea
Conditions
Explore the condition pages connected to this study.